Axsome Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$1.31 | -$1.07 | -$1.20 |
| Q2 2024 | 4 | -$1.43 | -$1.16 | -$1.31 |
| Q3 2024 | 3 | -$1.51 | -$1.23 | -$1.38 |
| Q4 2024 | 9 | -$1.36 | -$0.46 | -$0.99 |
| Q1 2025 | 4 | -$1.25 | -$0.63 | -$0.94 |
| Q2 2025 | 2 | -$0.67 | -$0.54 | -$0.61 |
| Q3 2025 | 2 | -$0.31 | -$0.26 | -$0.29 |
| Q4 2025 | 2 | $0.32 | $0.39 | $0.35 |
| Q1 2026 | 1 | $0.03 | $0.04 | $0.04 |
| Q2 2026 | 1 | $0.76 | $0.93 | $0.85 |
| Q3 2026 | 1 | $1.37 | $1.68 | $1.54 |
| Q4 2026 | 1 | $2.01 | $2.47 | $2.26 |
Axsome Therapeutics, Inc. Earnings Date And Information
Axsome Therapeutics, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-1.34 earnings per share for the quarter, topping analysts' consensus estimates of $-1.38 by $0.04. The company had revenue of 104.76 M for the quarter and had revenue of 270.60 M for the year. Axsome Therapeutics, Inc. has generated $-5 earnings per share over the last year ($-5.27 diluted earnings per share) and currently has a price-to-earnings ratio of -14.31. Axsome Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
Axsome Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$1.38 | -$1.34 | 0.04 | $98.37 M | $104.76 M |
| 08/05/2024 | Q2 2024 | -$1.30 | -$1.67 | -0.37 | $86.92 M | $87.17 M |
| 05/06/2024 | Q1 2024 | -$1.20 | -$1.44 | -0.24 | $75.00 M | |
| 02/23/2024 | Q4 2023 | -$2.08 | $71.53 M | |||
| 11/06/2023 | Q3 2023 | -$1.24 | -$1.32 | -0.08 | $54.87 M | $57.79 M |
| 08/07/2023 | Q2 2023 | -$1.24 | -$1.54 | -0.3 | $40.88 M | $46.70 M |
| 05/08/2023 | Q1 2023 | -$0.26 | $94.58 M | |||
| 02/27/2023 | Q4 2022 | -$1.54 | $24.37 M | |||
| 11/07/2022 | Q3 2022 | -$1.10 | -$1.13 | -0.03 | $16.64 M | $16.85 M |
| 08/09/2022 | Q2 2022 | -$1.19 | -$1.10 | 0.09 | $6.92 M | $8.82 M |
| 05/02/2022 | Q1 2022 | -$1.02 | -$1.07 | -0.05 | $0 | |
| 03/01/2022 | Q4 2021 | -$0.99 | -$0.90 | 0.09 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.94 | -$0.93 | 0.01 | $0 | |
| 08/09/2021 | Q2 2021 | -$0.88 | -$0.86 | 0.02 | $0 | |
| 05/10/2021 | Q1 2021 | -$0.83 | -$0.78 | 0.05 | $0 | |
| 03/01/2021 | Q4 2020 | -$0.73 | -$0.78 | -0.05 | $0 | |
| 11/06/2020 | Q3 2020 | -$0.61 | $0 | |||
| 08/10/2020 | Q2 2020 | -$0.54 | -$0.49 | 0.05 | $0 | |
| 05/11/2020 | Q1 2020 | -$0.88 | $0 | |||
| 03/12/2020 | Q4 2019 | -$0.51 | -$0.71 | -0.2 | $0 |
Axsome Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Axsome Therapeutics, Inc.'s earnings date?
Axsome Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
-
Did Axsome Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Axsome Therapeutics, Inc. (:AXSM) reported $-1.34 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.38 by $0.04.
-
How can I listen to Axsome Therapeutics, Inc.'s earnings conference call?
The conference call for Axsome Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Axsome Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Axsome Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Axsome Therapeutics, Inc. generate each year?
Axsome Therapeutics, Inc. (:AXSM) has a recorded annual revenue of $270.60 M.
-
How much profit does Axsome Therapeutics, Inc. generate each year?
Axsome Therapeutics, Inc. (:AXSM) has a recorded net income of $270.60 M. Axsome Therapeutics, Inc. has generated $-5.27 earnings per share over the last four quarters.
-
What is Axsome Therapeutics, Inc.'s price-to-earnings ratio?
Axsome Therapeutics, Inc. (:AXSM) has a price-to-earnings ratio of -14.31 and price/earnings-to-growth ratio is 46.59.
